Helsinn Announces Launch of Oral Formulation of Akynzeo® in China

Lugano, Switzerland, June 9 (Korea Bizwire) – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to announce that the oral formulation of Akynzeo® for the treatment of chemotherapy-induced nausea and vomiting (CINV) has been launched in China. Helsinn’s partner Mundipharma (China) Pharmaceutical Company Ltd. has exclusive marketing, promotion [...]